Ignite Creation Date:
2024-05-05 @ 4:57 PM
Last Modification Date:
2024-10-26 @ 9:26 AM
Study NCT ID:
NCT00354120
Status:
COMPLETED
Last Update Posted:
2023-03-10
First Post:
2006-07-19
Brief Title:
Thymoglobuline Versus Alemtuzumab in Patients Undergoing Allogeneic Transplant
Sponsor:
Gruppo Italiano Trapianto di Midollo Osseo
Organization:
Gruppo Italiano Trapianto di Midollo Osseo
Organization Data
Organization:
Gruppo Italiano Trapianto di Midollo Osseo
Class:
OTHER
Study ID:
EudraCT2005-000805-68
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Gruppo Italiano Trapianto di Midollo Osseo
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None